文献速递慢性肾脏病

血管微环境在肾小管间质纤维化调控中的作用

The role of the vascular niche in regulating kidney tubulointerstitial fibrosis.
PubMed 文献 · Kidney Int · 2025-11-21

本文为综述,围绕血管微环境(vascular niche)在肾小管间质纤维化及慢性肾脏病(CKD)进展中的作用展开讨论。文中指出,管周毛细血管稀疏长期被视为肾小管间质纤维化的标志和CKD进展的关键生物学改变,但近期文献提出纤维化与促血管生成通路上调密切相关,管周毛细血管稀疏可能是结果而非原因。作者认为血管微环境是调控血管稳态、关键分子信号通路和炎症的动态实体,可能通过影响细胞分化和免疫反应改变肾脏疾病进程。

要点

  • 管周毛细血管稀疏是肾小管间质纤维化的标志,但其因果地位受到近期文献挑战。
  • 促血管生成通路上调可能与肾小管间质纤维化和CKD进展密切相关。
  • 血管微环境或成为限制纤维化、延缓CKD进展的潜在治疗靶点。

核心结论

  • 肾小管间质纤维化是几乎所有形式CKD进展的共同终末通路,血管微环境是调控该过程的动态实体。
  • 管周毛细血管稀疏可能是肾小管间质纤维化的结果而非原因,促血管生成通路上调与纤维化和CKD进展密切相关。
  • 理解血管微环境细胞与分子组分的复杂相互作用,可能有助于发现限制肾小管间质纤维化和阻止CKD进展的新治疗靶点。

研究设计与样本

  • 本文为综述,检索范围未在原文中报告。

主要发现

  • 管周毛细血管稀疏导致缺氧和缺血,长期被视为肾小管间质纤维化的标志性病理特征和CKD进展的关键生物学改变。
  • 近期文献提出肾小管间质纤维化和CKD进展与促血管生成通路上调密切相关,据此管周毛细血管稀疏可能是后果而非原因。
  • 越来越多的证据提示血管微环境是调控血管稳态、关键分子信号通路和炎症的动态实体。
  • 血管微环境可能通过影响细胞分化和免疫反应改变多种肾脏疾病的病程。

临床怎么用

  • 未来治疗策略可能包括调控血管微环境内血管分泌因子的分泌。
  • 未来治疗策略可能包括调节血管微环境内免疫细胞活性。
  • 未来治疗策略可能包括干预内皮细胞和周细胞向肌成纤维细胞转化,后者是肾脏纤维生成的关键角色。

局限性

  • 本文为综述,原文未报告检索范围及纳入标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic kidney disease (CKD) is a substantial global health problem with devastating impacts on patients' morbidity and mortality. Kidney fibrosis, specifically tubulointerstitial fibrosis, is considered the final common pathway in the progression of virtually all forms of CKD. Peritubular capillary rarefaction, which refers to a decrease in peritubular capillary density leading to hypoxic and ischemic conditions, has long been recognized as a hallmark pathologic feature of tubulointerstitial fibrosis and a pivotal biological alteration leading to CKD progression. Conversely, recent literature has challenged this paradigm by proposing that tubulointerstitial fibrosis and CKD progression are closely associated with the upregulation of proangiogenic pathways. As such, peritubular capillary rarefaction may be a consequence rather than a cause of tubulointerstitial fibrosis. Furthermore, a growing body of evidence suggests that the microenvironment of the kidney vasculature, which may be referred to as the vascular niche, is a dynamic entity that regulates vascular homeostasis, key molecular signaling pathways, and inflammation. In this review, we detail how the vascular niche may modify the course of various kidney diseases by influencing cell differentiation and the immune response. Understanding the complex interplay between the cellular and molecular components of the vascular niche may eventually lead to the identification of novel therapeutic targets to limit tubulointerstitial fibrosis and halt CKD progression. This could potentially involve modulating the secretion of angiocrine factors, regulating immune cell activity within the vascular niche, or interfering with the transformation of endothelial cells and pericytes into myofibroblasts, which are key players in kidney fibrogenesis.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Sohail MA, El-Achkar TM, Dagher PC, et al. The role of the vascular niche in regulating kidney tubulointerstitial fibrosis. Kidney Int. 2025. PMID: 41276016. doi:10.1016/j.kint.2025.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。